TY - JOUR
T1 - Trends in laparoscopic and robotic surgery among gynecologic oncologists
T2 - A survey update
AU - Mabrouk, Mohamed
AU - Frumovitz, Michael
AU - Greer, Marilyn
AU - Sharma, Sheena
AU - Schmeler, Kathleen M.
AU - Soliman, Pamela T.
AU - Ramirez, Pedro T.
PY - 2009/3
Y1 - 2009/3
N2 - Objectives: To assess the use of traditional and robotic assisted laparoscopy by Society of Gynecologic Oncology (SGO) members and to compare the results with those of our published survey in 2004. Methods: Surveys were mailed to SGO members, and anonymous responses were collected by mail or through a web site. Data were analyzed and compared with those of our previous survey. In addition, we gathered information on the effect of robotic assisted surgery on the management of gynecologic malignancies. Results: Three hundred eighty-eight (46%) of 850 SGO members responded to the survey. Three hundred fifty-two (91%) indicated that they performed laparoscopic surgery in their practice (compared with 84% in the 2004 survey). The three most common laparoscopic procedures were laparoscopic hysterectomy and staging for uterine cancer (43%), diagnostic laparoscopy for adnexal masses (39%), and prophylactic bilateral oophorectomy for high-risk women (11%). Although 76% of respondents had received either limited or no laparoscopic training during their fellowship, 78% now believe that maximum or much emphasis should be placed on laparoscopic training (55% in the 2004 survey). Twenty-four percent of respondents indicated that they performed robotic assisted surgery, with 66% indicating that they planned to increase their use of the procedure in the next year. Conclusions: We found an overall increase in the use of and perceived indications for minimally invasive surgery in gynecologic oncology among SGO members. Endometrial cancer staging has become an accepted indication for laparoscopy. In addition, most respondents were planning on increasing their use of robotic assisted surgery in the next year.
AB - Objectives: To assess the use of traditional and robotic assisted laparoscopy by Society of Gynecologic Oncology (SGO) members and to compare the results with those of our published survey in 2004. Methods: Surveys were mailed to SGO members, and anonymous responses were collected by mail or through a web site. Data were analyzed and compared with those of our previous survey. In addition, we gathered information on the effect of robotic assisted surgery on the management of gynecologic malignancies. Results: Three hundred eighty-eight (46%) of 850 SGO members responded to the survey. Three hundred fifty-two (91%) indicated that they performed laparoscopic surgery in their practice (compared with 84% in the 2004 survey). The three most common laparoscopic procedures were laparoscopic hysterectomy and staging for uterine cancer (43%), diagnostic laparoscopy for adnexal masses (39%), and prophylactic bilateral oophorectomy for high-risk women (11%). Although 76% of respondents had received either limited or no laparoscopic training during their fellowship, 78% now believe that maximum or much emphasis should be placed on laparoscopic training (55% in the 2004 survey). Twenty-four percent of respondents indicated that they performed robotic assisted surgery, with 66% indicating that they planned to increase their use of the procedure in the next year. Conclusions: We found an overall increase in the use of and perceived indications for minimally invasive surgery in gynecologic oncology among SGO members. Endometrial cancer staging has become an accepted indication for laparoscopy. In addition, most respondents were planning on increasing their use of robotic assisted surgery in the next year.
KW - Evaluation
KW - Gynecologic oncology
KW - Laparoscopy
UR - http://www.scopus.com/inward/record.url?scp=60449096361&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=60449096361&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2008.11.037
DO - 10.1016/j.ygyno.2008.11.037
M3 - Article
C2 - 19138793
AN - SCOPUS:60449096361
VL - 112
SP - 501
EP - 505
JO - Gynecologic oncology
JF - Gynecologic oncology
SN - 0090-8258
IS - 3
ER -